Latigo Biotherapeutics Inc. filed to raise capital via an initial public offering, signaling a potential IPO as soon as this quarter. The move aligns with a broader uptick in biotech listings, though the article provides no pricing or valuation terms, keeping immediate market impact limited.
Latigo Biotherapeutics Inc. filed to raise capital via an initial public offering, signaling a potential IPO as soon as this quarter. The move aligns with a broader uptick in biotech listings, though the article provides no pricing or valuation terms, keeping immediate market impact limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.10
